Shares in Regeneron (NSDQ:REGN) gained today after the biopharmaceutical company crushed earnings expectations on Wall Street with its 3rd quarter results.
The Tarrytown, New York-based company posted profits of $264.8 million, or $2.27 per share, on sales of $1.22 billion for the 3 months ended September 30, for bottom-line growth of 26% on sales growth of 7.3% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.